|
시장보고서
상품코드
1697960
분자 감염증 검사 시장 규모, 점유율, 동향, 업계 분석 : 제품 및 서비스별, 유형별, 검사 유형별, 질환별, 기술별, 최종사용자별, 지역별 - 시장 예측(2025-2034년)Molecular Infectious Disease Testing Market Size, Share, Trends, Industry Analysis Report: By Product & Service, Type, Test Type, Disease, Technology, End User, and Region - Market Forecast, 2025-2034 |
||||||
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
Polaris Market Research의 최신 조사에 따르면 분자 감염증 검사 시장 규모는 2034년까지 347억 3,000만 달러에 달할 전망입니다. 이 리포트는 현재 시장 역학의 상세 인사이트와 향후 시장 성장에 관한 분석을 제공하고 있습니다.
분자 감염병 검사란 병원체의 유전물질을 검출 및 분석하여 정확하고 조기에 질병을 확인할 수 있는 첨단 진단 기술을 말합니다. 분자 감염병 검사 시장의 주요 동향은 한 번의 검사로 여러 병원체를 동시에 검출할 수 있는 멀티플렉스 분자진단법의 채택이 증가하고 있다는 점입니다. 이러한 발전은 진단 효율을 향상시키고, 납기를 단축시키며, 임상적 의사결정을 개선합니다. 특히 급성기 의료 현장에서 신속하고 광범위한 진단 솔루션에 대한 수요가 증가함에 따라 다중 분석이 일상적인 분자 검사에 통합되어 감염 관리에서 그 역할이 더욱 강화되고 있습니다.
분자 감염 검사 시장 수요를 형성하는 또 다른 주요 동향은 진단 워크플로우에서 자동화와 인공지능(AI)의 통합이 증가하고 있다는 점입니다. 자동화된 분자 검사 플랫폼은 검사실의 효율성을 개선하고 인적 오류를 최소화하며 검사 수요 증가에 대응할 수 있는 확장성을 향상시키고, AI 기반 데이터 분석은 결과 해석을 더욱 정교하게 만들어 보다 정확한 진단과 예측 분석을 촉진하고 있습니다. 자동화와 AI의 결합은 분자진단을 간소화하고, 다양한 의료 환경에서 검사를 보다 쉽게 이용할 수 있고 신뢰할 수 있게 하여 분자 감염 검사 시장의 성장을 가속화하고 있습니다.
분자 감염 검사 시장 : 분석 개요
질환별로는 성병(STD) 분야가 2024년 분자 감염 검사 시장 점유율을 주도할 것으로 예상되며, 이는 STI 발병률 증가와 정밀하고 빠른 진단 솔루션에 대한 수요 증가에 기인한 것으로 분석됩니다.
제품 및 서비스별로는 시약 및 키트 분야가 예측 기간 중 가장 빠른 시장 성장을 보일 것으로 예상되며, 이는 다양한 의료 환경에서 분자진단 검사의 사용 증가에 기인합니다.
북미는 2024년 분자 감염 검사 시장 매출 점유율 1위로 부상했는데, 이는 의료 인프라가 잘 갖추어져 있고, 첨단 진단 기술 채택률이 높으며, 분자 검사를 지원하는 규제 프레임워크가 잘 갖추어져 있기 때문입니다.
아시아태평양의 분자 감염 검사 시장은 의료 투자 확대, 질병 조기 발견에 대한 인식 증가, 감염성 질환의 유병률 증가를 배경으로 예측 기간 중 가장 높은 성장률을 보일 것으로 예상됩니다.
세계의 주요 시장 참여 기업에는 Abbott, Danaher Corporation, bioMerieux SA, F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories, Inc., Agilent Technologies, Inc., Becton, Dickinson and Company, Hologic, Inc. (Gen-Probe), Illumina, Inc., Grifols S.A., Qiagen, Siemens Healthineers AG, Sysmex Corporation, Bruker Corporation, Thermo Fisher Scientific 등이 있습니다.
목차
제1장 서론
제2장 개요
제3장 분석 방법
제4장 세계의 분자 감염증 검사 시장 인사이트
- 시장 스냅숏
- 분자 감염증 검사 시장 역학
- 촉진요인과 기회
- 감염증의 증가
- 분자진단에서의 급속한 기술 진보
- 억제요인과 과제
- 일관성 없는 환급 정책
- 촉진요인과 기회
- PESTLE 분석
- 분자 감염증 검사 시장 : 유통 채널 동향
- 밸류체인 분석
제5장 세계의 분자 감염증 검사 시장 : 제품·서비스별
- 주요 분석 결과
- 서론
- 시약·키트
- 기기
- 서비스·소프트웨어
제6장 세계의 분자 감염증 검사 시장 : 유형별
- 주요 분석 결과
- 서론
- 멀티플렉스 검사
- 싱글플렉스 검사
제7장 세계의 분자 감염증 검사 시장 : 검사 유형별
- 주요 분석 결과
- 서론
- 임상 검사
- PoC(Point-of-Care) 검사
제8장 세계의 분자 감염증 검사 시장 : 질환별
- 주요 분석 결과
- 서론
- 호흡기 감염증
- 소화기 감염증
- 성감염증
- 원내감염
- 질염
- 수막염
- 매개성 질환
- 기타 감염증
제9장 세계의 분자 감염증 검사 시장 : 기술별
- 주요 분석 결과
- 서론
- 중합효소 연쇄 반응(PCR)
- 등온핵산증폭기술(INACT)
- DNA 시퀀싱·차세대 시퀀싱
- in situ 하이브리다이제이션
- DNA 마이크로어레이
- 기타
제10장 세계의 분자 감염증 검사 시장 : 최종사용자별
- 주요 분석 결과
- 서론
- 진단 검사실
- 병원·진료소
- 기타
제11장 세계의 분자 감염증 검사 시장 : 지역별
- 주요 분석 결과
- 서론
- 분자 감염증 검사 시장 분석 : 지역별(2020-2034년)
- 북미
- 북미 : 제품·서비스별(2020-2034년)
- 북미 : 유형별(2020-2034년)
- 북미 : 검사 유형별(2020-2034년)
- 북미 : 질환별(2020-2034년)
- 북미 : 기술별(2020-2034년)
- 북미 : 최종사용자별(2020-2034년)
- 미국
- 캐나다
- 유럽
- 유럽 : 제품·서비스별(2020-2034년)
- 유럽 : 유형별(2020-2034년)
- 유럽 : 검사 유형별(2020-2034년)
- 유럽 : 질환별(2020-2034년)
- 유럽 : 기술별(2020-2034년)
- 유럽 : 최종사용자별(2020-2034년)
- 영국
- 프랑스
- 독일
- 이탈리아
- 스페인
- 네덜란드
- 러시아
- 기타 유럽
- 아시아태평양
- 아시아태평양 : 제품·서비스별, 2020-2034년
- 아시아태평양 : 유형별(2020-2034년)
- 아시아태평양 : 검사 유형별(2020-2034년)
- 아시아태평양 : 질환별(2020-2034년)
- 아시아태평양 : 기술별(2020-2034년)
- 아시아태평양 : 최종사용자별(2020-2034년)
- 중국
- 인도
- 말레이시아
- 일본
- 인도네시아
- 한국
- 호주
- 기타 아시아태평양
- 중동 및 아프리카
- 중동 및 아프리카 : 제품·서비스별(2020-2034년)
- 중동 및 아프리카 : 유형별(2020-2034년)
- 중동 및 아프리카 : 검사 유형별(2020-2034년)
- 중동 및 아프리카 : 질환별(2020-2034년)
- 중동 및 아프리카 : 기술별(2020-2034년)
- 중동 및 아프리카 : 최종사용자별(2020-2034년)
- 사우디아라비아
- 아랍에미리트
- 이스라엘
- 남아프리카공화국
- 기타 중동 및 아프리카
- 라틴아메리카
- 라틴아메리카 : 제품·서비스별(2020-2034년)
- 라틴아메리카 : 유형별(2020-2034년)
- 라틴아메리카 : 검사 유형별(2020-2034년)
- 라틴아메리카 : 질환별(2020-2034년)
- 라틴아메리카 : 기술별(2020-2034년)
- 라틴아메리카 : 최종사용자별(2020-2034년)
- 멕시코
- 브라질
- 아르헨티나
- 기타 라틴아메리카
제12장 경쟁 구도
- 사업 확대·기업 인수 분석
- 사업 확대
- 기업 인수
- 제휴/협업/합의/공개
제13장 기업 개요
- Abbott
- Agilent Technologies, Inc.
- Becton, Dickinson and Company
- bioMérieux SA
- Bio-Rad Laboratories, Inc.
- Bruker Corporation
- Danaher Corporation
- F. Hoffmann-La Roche Ltd
- Grifols S.A.
- Hologic, Inc.(Gen-Probe)
- Illumina, Inc.
- Qiagen
- Siemens Healthineers AG
- Sysmex Corporation
- Thermo Fisher Scientific
The molecular infectious disease testing market size is expected to reach USD 34.73 billion by 2034, according to a new study by Polaris Market Research. The report "Molecular Infectious Disease Testing Market Share, Size, Trends, Industry Analysis Report: By Product & Service, Type (Multiplex Testing and Singleplex Testing), Test Type, Disease, Technology, End User, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa); Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.
Molecular infectious disease testing refers to advanced diagnostic techniques that detect and analyze the genetic material of pathogens to enable precise and early disease identification. A major molecular infectious disease testing market trend is the increasing adoption of multiplex molecular diagnostics, which allow the simultaneous detection of multiple pathogens in a single test. This advancement improves diagnostic efficiency, reduces turnaround time, and improves clinical decision-making. The growing demand for rapid and wide diagnostic solutions, particularly in acute care settings, is further driving the integration of multiplex assays into routine molecular testing, strengthening their role in infectious disease management.
Another major trend shaping the molecular infectious disease testing market demand is the rising integration of automation and artificial intelligence (AI) in diagnostic workflows. Automated molecular testing platforms are improving laboratory efficiency, minimizing human errors, and improving scalability to meet the increasing testing demand. AI-driven data analysis is further refining result interpretation, facilitating more accurate diagnoses and predictive analytics. The combination of automation and AI is streamlining molecular diagnostics, making testing more accessible and reliable across various healthcare settings, thereby accelerating molecular infectious disease testing market growth.
Molecular Infectious Disease Testing Market Report Highlights
In terms of disease, the sexually transmitted disease (STD) segment led the molecular infectious disease testing market share in 2024, driven by the rising incidence of STIs and the growing need for precise and early diagnostic solutions.
Based on product & service, the reagents & kits segment is anticipated to experience the most rapid growth in the market during the forecast period, fueled by the increasing utilization of molecular diagnostic tests across various healthcare settings.
North America emerged as the leading region in the global molecular infectious disease testing market revenue share in 2024, attributed to its well-developed healthcare infrastructure, high adoption of advanced diagnostic technologies, and a robust regulatory framework supporting molecular testing.
The molecular infectious disease testing market in Asia Pacific is expected to witness the highest growth rate during the forecast period, driven by expanding healthcare investments, greater awareness of early disease detection, and a rising prevalence of infectious diseases.
A few global key market players include Abbott; Danaher Corporation; bioMerieux SA; F. Hoffmann-La Roche Ltd; Bio-Rad Laboratories, Inc.; Agilent Technologies, Inc.; Becton, Dickinson and Company; Hologic, Inc. (Gen-Probe); Illumina, Inc., Grifols S.A.; Qiagen; Siemens Healthineers AG; Sysmex Corporation; Bruker Corporation; and Thermo Fisher Scientific.
Polaris Market Research has segmented the molecular infectious disease testing market report on the basis of product & service, type, test type, disease, technology, end user, and region:
By Product & Service Outlook (Revenue, USD Billion, 2020-2034)
- Reagents & Kits
- Instruments
- Services & Software
By Type Outlook (Revenue, USD Billion, 2020-2034)
- Multiplex Testing
- Singleplex Testing
By Test Type Outlook (Revenue, USD Billion, 2020-2034)
- Laboratory Tests
- Point-of-Care Tests
By Disease Outlook (Revenue, USD Billion, 2020-2034)
- Respiratory Infectious Diseases
- Gastrointestinal Infectious Diseases
- Sexually Transmitted Diseases
- Hospital-Acquired Infections
- Vaginitis
- Meningitis
- Vector-Borne Diseases
- Other Infectious Diseases
By Technology Outlook (Revenue, USD Billion, 2020-2034)
- Polymerase Chain Reaction
- Isothermal Nucleic Acid Amplification Technology
- DNA-Sequencing & Next-Generation Sequencing
- In-Situ Hybridization
- DNA Microarrays
- Others
By End User Outlook (Revenue, USD Billion, 2020-2034)
- Diagnostic Laboratories
- Hospitals & Clinics
- Others
By Regional Outlook (Revenue, USD Billion, 2020-2034)
- North America
- US
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Netherlands
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Indonesia
- Malaysia
- Vietnam
- Australia
- Rest of Asia Pacific
- Latin America
- Argentina
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- UAE
- Saudi Arabia
- Israel
- South Africa
- Rest of Middle East & Africa
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
- 2.1. Market Highlights
3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
4. Global Molecular Infectious Disease Testing Market Insights
- 4.1. Molecular Infectious Disease Testing Market - Distribution Channel Snapshot
- 4.2. Molecular Infectious Disease Testing Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Rising Cases of Infectious Diseases
- 4.2.1.2. Rapid Technological Advancements in Molecular Diagnostics
- 4.2.2. Restraints and Challenges
- 4.2.2.1. Inconsistent Reimbursement Policies
- 4.2.1. Drivers and Opportunities
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. Molecular Infectious Disease Testing Market Distribution Channel Trends
- 4.6. Value Chain Analysis
5. Global Molecular Infectious Disease Testing Market, by Product & Service
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
- 5.3. Reagents & Kits
- 5.3.1. Global Molecular Infectious Disease Testing Market, by Pan-based Molecular Infectious Disease Testing, by Region, 2020-2034 (USD Billion)
- 5.4. Instruments
- 5.4.1. Global Molecular Infectious Disease Testing Market, by Instruments, by Region, 2020-2034 (USD Billion)
- 5.5. Services & Software
- 5.5.1. Global Molecular Infectious Disease Testing Market, by Services & Software, by Region, 2020-2034 (USD Billion)
6. Global Molecular Infectious Disease Testing Market, by Type
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
- 6.3. Multiplex Testing
- 6.3.1. Global Molecular Infectious Disease Testing Market, by Multiplex Testing, by Region, 2020-2034 (USD Billion)
- 6.4. Singleplex Testing
- 6.4.1. Global Molecular Infectious Disease Testing Market, by Singleplex Testing, by Region, 2020-2034 (USD Billion)
7. Global Molecular Infectious Disease Testing Market, by Test Type
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
- 7.3. Laboratory Tests
- 7.3.1. Global Molecular Infectious Disease Testing Market, by Laboratory Tests, by Region, 2020-2034 (USD Billion)
- 7.4. Point-of-Care Tests
- 7.4.1. Global Molecular Infectious Disease Testing Market, by Point-of-Care Tests, by Region, 2020-2034 (USD Billion)
8. Global Molecular Infectious Disease Testing Market, by Disease
- 8.1. Key Findings
- 8.2. Introduction
- 8.2.1. Global Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
- 8.3. Respiratory Infectious Diseases
- 8.3.1. Global Molecular Infectious Disease Testing Market, by Respiratory Infectious Diseases, by Region, 2020-2034 (USD Billion)
- 8.4. Gastrointestinal Infectious Diseases
- 8.4.1. Global Molecular Infectious Disease Testing Market, by Gastrointestinal Infectious Diseases, by Region, 2020-2034 (USD Billion)
- 8.5. Sexually Transmitted Diseases
- 8.5.1. Global Molecular Infectious Disease Testing Market, by Sexually Transmitted Diseases, by Region, 2020-2034 (USD Billion)
- 8.6. Hospital-Acquired Infections
- 8.6.1. Global Molecular Infectious Disease Testing Market, by Hospital-Acquired Infections, by Region, 2020-2034 (USD Billion)
- 8.7. Vaginitis
- 8.7.1. Global Molecular Infectious Disease Testing Market, by Vaginitis Diseases, by Region, 2020-2034 (USD Billion)
- 8.8. Meningitis
- 8.8.1. Global Molecular Infectious Disease Testing Market, by Meningitis, by Region, 2020-2034 (USD Billion)
- 8.9. Vector-Borne Diseases
- 8.9.1. Global Molecular Infectious Disease Testing Market, by Vector-Borne Diseases, by Region, 2020-2034 (USD Billion)
- 8.10. Other Infectious Diseases
- 8.10.1. Global Molecular Infectious Disease Testing Market, by Other Infectious Diseases, by Region, 2020-2034 (USD Billion)
9. Global Molecular Infectious Disease Testing Market, by Technology
- 9.1. Key Findings
- 9.2. Introduction
- 9.2.1. Global Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
- 9.3. Polymerase Chain Reaction
- 9.3.1. Global Molecular Infectious Disease Testing Market, by Polymerase Chain Reaction, by Region, 2020-2034 (USD Billion)
- 9.4. Isothermal Nucleic Acid Amplification Technology
- 9.4.1. Global Molecular Infectious Disease Testing Market, by Isothermal Nucleic Acid Amplification Technology, by Region, 2020-2034 (USD Billion)
- 9.5. DNA-Sequencing & Next-Generation Sequencing
- 9.5.1. Global Molecular Infectious Disease Testing Market, by DNA-Sequencing & Next-Generation Sequencing, by Region, 2020-2034 (USD Billion)
- 9.6. In-Situ Hybridization
- 9.6.1. Global Molecular Infectious Disease Testing Market, by In-Situ Hybridization, by Region, 2020-2034 (USD Billion)
- 9.7. DNA Microarrays
- 9.7.1. Global Molecular Infectious Disease Testing Market, by DNA Microarrays, by Region, 2020-2034 (USD Billion)
- 9.8. Others
- 9.8.1. Global Molecular Infectious Disease Testing Market, by Others, by Region, 2020-2034 (USD Billion)
10. Global Molecular Infectious Disease Testing Market, by End User
- 10.1. Key Findings
- 10.2. Introduction
- 10.2.1. Global Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
- 10.3. Diagnostic Laboratories
- 10.3.1. Global Molecular Infectious Disease Testing Market, by Diagnostic Laboratories, by Region, 2020-2034 (USD Billion)
- 10.4. Hospitals & Clinics
- 10.4.1. Global Molecular Infectious Disease Testing Market, by Hospitals & Clinics, by Region, 2020-2034 (USD Billion)
- 10.5. Others
- 10.5.1. Global Molecular Infectious Disease Testing Market, by Others, by Region, 2020-2034 (USD Billion)
11. Global Molecular Infectious Disease Testing Market, by Geography
- 11.1. Key Findings
- 11.2. Introduction
- 11.2.1. Molecular Infectious Disease Testing Market Assessment, By Geography, 2020-2034 (USD Billion)
- 11.3. Molecular Infectious Disease Testing Market - North America
- 11.3.1. North America: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
- 11.3.2. North America: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
- 11.3.3. North America: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
- 11.3.4. North America: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
- 11.3.5. North America: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
- 11.3.6. North America: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
- 11.3.7. Molecular Infectious Disease Testing Market - US
- 11.3.7.1. US: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
- 11.3.7.2. US: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
- 11.3.7.3. US: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
- 11.3.7.4. US: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
- 11.3.7.5. US: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
- 11.3.7.6. US: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
- 11.3.8. Molecular Infectious Disease Testing Market - Canada
- 11.3.8.1. Canada: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
- 11.3.8.2. Canada: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
- 11.3.8.3. Canada: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
- 11.3.8.4. Canada: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
- 11.3.8.5. Canada: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
- 11.3.8.6. Canada: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
- 11.4. Molecular Infectious Disease Testing Market - Europe
- 11.4.1. Europe: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
- 11.4.2. Europe: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
- 11.4.3. Europe: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
- 11.4.4. Europe: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
- 11.4.5. Europe: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
- 11.4.6. Europe: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
- 11.4.7. Molecular Infectious Disease Testing Market - UK
- 11.4.7.1. UK: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
- 11.4.7.2. UK: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
- 11.4.7.3. UK: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
- 11.4.7.4. UK: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
- 11.4.7.5. UK: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
- 11.4.7.6. UK: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
- 11.4.8. Molecular Infectious Disease Testing Market - France
- 11.4.8.1. France: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
- 11.4.8.2. France: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
- 11.4.8.3. France: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
- 11.4.8.4. France: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
- 11.4.8.5. France: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
- 11.4.8.6. France: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
- 11.4.9. Molecular Infectious Disease Testing Market - Germany
- 11.4.9.1. Germany: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
- 11.4.9.2. Germany: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
- 11.4.9.3. Germany: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
- 11.4.9.4. Germany: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
- 11.4.9.5. Germany: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
- 11.4.9.6. Germany: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
- 11.4.10. Molecular Infectious Disease Testing Market - Italy
- 11.4.10.1. Italy: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
- 11.4.10.2. Italy: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
- 11.4.10.3. Italy: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
- 11.4.10.4. Italy: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
- 11.4.10.5. Italy: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
- 11.4.10.6. Italy: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
- 11.4.11. Molecular Infectious Disease Testing Market - Spain
- 11.4.11.1. Spain: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
- 11.4.11.2. Spain: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
- 11.4.11.3. Spain: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
- 11.4.11.4. Spain: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
- 11.4.11.5. Spain: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
- 11.4.11.6. Spain: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
- 11.4.12. Molecular Infectious Disease Testing Market - Netherlands
- 11.4.12.1. Netherlands: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
- 11.4.12.2. Netherlands: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
- 11.4.12.3. Netherlands: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
- 11.4.12.4. Netherlands: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
- 11.4.12.5. Netherlands: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
- 11.4.12.6. Netherlands: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
- 11.4.13. Molecular Infectious Disease Testing Market - Russia
- 11.4.13.1. Russia: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
- 11.4.13.2. Russia: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
- 11.4.13.3. Russia: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
- 11.4.13.4. Russia: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
- 11.4.13.5. Russia: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
- 11.4.13.6. Russia: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
- 11.4.14. Molecular Infectious Disease Testing Market - Rest of Europe
- 11.4.14.1. Rest of Europe: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
- 11.4.14.2. Rest of Europe: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
- 11.4.14.3. Rest of Europe: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
- 11.4.14.4. Rest of Europe: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
- 11.4.14.5. Rest of Europe: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
- 11.4.14.6. Rest of Europe: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
- 11.5. Molecular Infectious Disease Testing Market - Asia Pacific
- 11.5.1. Asia Pacific: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
- 11.5.2. Asia Pacific: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
- 11.5.3. Asia Pacific: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
- 11.5.4. Asia Pacific: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
- 11.5.5. Asia Pacific: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
- 11.5.6. Asia Pacific: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
- 11.5.7. Molecular Infectious Disease Testing Market - China
- 11.5.7.1. China: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
- 11.5.7.2. China: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
- 11.5.7.3. China: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
- 11.5.7.4. China: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
- 11.5.7.5. China: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
- 11.5.7.6. China: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
- 11.5.8. Molecular Infectious Disease Testing Market - India
- 11.5.8.1. India: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
- 11.5.8.2. India: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
- 11.5.8.3. India: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
- 11.5.8.4. India: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
- 11.5.8.5. India: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
- 11.5.8.6. India: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
- 11.5.9. Molecular Infectious Disease Testing Market - Malaysia
- 11.5.9.1. Malaysia: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
- 11.5.9.2. Malaysia: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
- 11.5.9.3. Malaysia: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
- 11.5.9.4. Malaysia: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
- 11.5.9.5. Malaysia: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
- 11.5.9.6. Malaysia: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
- 11.5.10. Molecular Infectious Disease Testing Market - Japan
- 11.5.10.1. Japan: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
- 11.5.10.2. Japan: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
- 11.5.10.3. Japan: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
- 11.5.10.4. Japan: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
- 11.5.10.5. Japan: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
- 11.5.10.6. Japan: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
- 11.5.11. Molecular Infectious Disease Testing Market - Indonesia
- 11.5.11.1. Indonesia: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
- 11.5.11.2. Indonesia: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
- 11.5.11.3. Indonesia: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
- 11.5.11.4. Indonesia: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
- 11.5.11.5. Indonesia: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
- 11.5.11.6. Indonesia: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
- 11.5.12. Molecular Infectious Disease Testing Market - South Korea
- 11.5.12.1. South Korea: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
- 11.5.12.2. South Korea: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
- 11.5.12.3. South Korea: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
- 11.5.12.4. South Korea: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
- 11.5.12.5. South Korea: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
- 11.5.12.6. South Korea: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
- 11.5.13. Molecular Infectious Disease Testing Market - Australia
- 11.5.13.1. Australia: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
- 11.5.13.2. Australia: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
- 11.5.13.3. Australia: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
- 11.5.13.4. Australia: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
- 11.5.13.5. Australia: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
- 11.5.13.6. Australia: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
- 11.5.14. Molecular Infectious Disease Testing Market - Rest of Asia Pacific
- 11.5.14.1. Rest of Asia Pacific: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
- 11.5.14.2. Rest of Asia Pacific: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
- 11.5.14.3. Rest of Asia Pacific: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
- 11.5.14.4. Rest of Asia Pacific: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
- 11.5.14.5. Rest of Asia Pacific: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
- 11.5.14.6. Rest of Asia Pacific: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
- 11.6. Molecular Infectious Disease Testing Market - Middle East & Africa
- 11.6.1. Middle East & Africa: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
- 11.6.2. Middle East & Africa: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
- 11.6.3. Middle East & Africa: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
- 11.6.4. Middle East & Africa: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
- 11.6.5. Middle East & Africa: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
- 11.6.6. Middle East & Africa: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
- 11.6.7. Molecular Infectious Disease Testing Market - Saudi Arabia
- 11.6.7.1. Saudi Arabia: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
- 11.6.7.2. Saudi Arabia: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
- 11.6.7.3. Saudi Arabia: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
- 11.6.7.4. Saudi Arabia: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
- 11.6.7.5. Saudi Arabia: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
- 11.6.7.6. Saudi Arabia: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
- 11.6.8. Molecular Infectious Disease Testing Market - UAE
- 11.6.8.1. UAE: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
- 11.6.8.2. UAE: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
- 11.6.8.3. UAE: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
- 11.6.8.4. UAE: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
- 11.6.8.5. UAE: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
- 11.6.8.6. UAE: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
- 11.6.9. Molecular Infectious Disease Testing Market - Israel
- 11.6.9.1. Israel: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
- 11.6.9.2. Israel: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
- 11.6.9.3. Israel: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
- 11.6.9.4. Israel: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
- 11.6.9.5. Israel: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
- 11.6.9.6. Israel: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
- 11.6.10. Molecular Infectious Disease Testing Market - South Africa
- 11.6.10.1. South Africa: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
- 11.6.10.2. South Africa: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
- 11.6.10.3. South Africa: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
- 11.6.10.4. South Africa: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
- 11.6.10.5. South Africa: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
- 11.6.10.6. South Africa: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
- 11.6.11. Molecular Infectious Disease Testing Market - Rest of Middle East & Africa
- 11.6.11.1. Rest of Middle East & Africa: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
- 11.6.11.2. Rest of Middle East & Africa: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
- 11.6.11.3. Rest of Middle East & Africa: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
- 11.6.11.4. Rest of Middle East & Africa: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
- 11.6.11.5. Rest of Middle East & Africa: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
- 11.6.11.6. Rest of Middle East & Africa: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
- 11.7. Molecular Infectious Disease Testing Market - Latin America
- 11.7.1. Latin America: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
- 11.7.2. Latin America: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
- 11.7.3. Latin America: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
- 11.7.4. Latin America: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
- 11.7.5. Latin America: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
- 11.7.6. Latin America: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
- 11.7.7. Molecular Infectious Disease Testing Market - Mexico
- 11.7.7.1. Mexico: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
- 11.7.7.2. Mexico: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
- 11.7.7.3. Mexico: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
- 11.7.7.4. Mexico: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
- 11.7.7.5. Mexico: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
- 11.7.7.6. Mexico: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
- 11.7.8. Molecular Infectious Disease Testing Market - Brazil
- 11.7.8.1. Brazil: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
- 11.7.8.2. Brazil: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
- 11.7.8.3. Brazil: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
- 11.7.8.4. Brazil: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
- 11.7.8.5. Brazil: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
- 11.7.8.6. Brazil: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
- 11.7.9. Molecular Infectious Disease Testing Market - Argentina
- 11.7.9.1. Argentina: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
- 11.7.9.2. Argentina: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
- 11.7.9.3. Argentina: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
- 11.7.9.4. Argentina: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
- 11.7.9.5. Argentina: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
- 11.7.9.6. Argentina: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
- 11.7.10. Molecular Infectious Disease Testing Market - Rest of Latin America
- 11.7.10.1. Rest of Latin America: Molecular Infectious Disease Testing Market, by Product & Service, 2020-2034 (USD Billion)
- 11.7.10.2. Rest of Latin America: Molecular Infectious Disease Testing Market, by Type, 2020-2034 (USD Billion)
- 11.7.10.3. Rest of Latin America: Molecular Infectious Disease Testing Market, by Test Type, 2020-2034 (USD Billion)
- 11.7.10.4. Rest of Latin America: Molecular Infectious Disease Testing Market, by Disease, 2020-2034 (USD Billion)
- 11.7.10.5. Rest of Latin America: Molecular Infectious Disease Testing Market, by Technology, 2020-2034 (USD Billion)
- 11.7.10.6. Rest of Latin America: Molecular Infectious Disease Testing Market, by End User, 2020-2034 (USD Billion)
12. Competitive Landscape
- 12.1. Expansion and Acquisition Analysis
- 12.1.1. Expansion
- 12.1.2. Acquisitions
- 12.2. Partnerships/Collaborations/Agreements/Exhibitions
13. Company Profiles
- 13.1. Abbott
- 13.1.1. Company Overview
- 13.1.2. Financial Performance
- 13.1.3. Product Benchmarking
- 13.1.4. Recent Development
- 13.2. Agilent Technologies, Inc.
- 13.2.1. Company Overview
- 13.2.2. Financial Performance
- 13.2.3. Product Benchmarking
- 13.2.4. Recent Development
- 13.3. Becton, Dickinson and Company
- 13.3.1. Company Overview
- 13.3.2. Financial Performance
- 13.3.3. Product Benchmarking
- 13.3.4. Recent Development
- 13.4. bioMérieux SA
- 13.4.1. Company Overview
- 13.4.2. Financial Performance
- 13.4.3. Product Benchmarking
- 13.4.4. Recent Development
- 13.5. Bio-Rad Laboratories, Inc.
- 13.5.1. Company Overview
- 13.5.2. Financial Performance
- 13.5.3. Product Benchmarking
- 13.5.4. Recent Development
- 13.6. Bruker Corporation
- 13.6.1. Company Overview
- 13.6.2. Financial Performance
- 13.6.3. Product Benchmarking
- 13.6.4. Recent Development
- 13.7. Danaher Corporation
- 13.7.1. Company Overview
- 13.7.2. Financial Performance
- 13.7.3. Product Benchmarking
- 13.7.4. Recent Development
- 13.8. F. Hoffmann-La Roche Ltd
- 13.8.1. Company Overview
- 13.8.2. Financial Performance
- 13.8.3. Product Benchmarking
- 13.8.4. Recent Development
- 13.9. Grifols S.A.
- 13.9.1. Company Overview
- 13.9.2. Financial Performance
- 13.9.3. Product Benchmarking
- 13.9.4. Recent Development
- 13.10. Hologic, Inc. (Gen-Probe)
- 13.10.1. Company Overview
- 13.10.2. Financial Performance
- 13.10.3. Product Benchmarking
- 13.10.4. Recent Development
- 13.11. Illumina, Inc.
- 13.11.1. Company Overview
- 13.11.2. Financial Performance
- 13.11.3. Product Benchmarking
- 13.11.4. Recent Development
- 13.12. Qiagen
- 13.12.1. Company Overview
- 13.12.2. Financial Performance
- 13.12.3. Product Benchmarking
- 13.12.4. Recent Development
- 13.13. Siemens Healthineers AG
- 13.13.1. Company Overview
- 13.13.2. Financial Performance
- 13.13.3. Product Benchmarking
- 13.13.4. Recent Development
- 13.14. Sysmex Corporation
- 13.14.1. Company Overview
- 13.14.2. Financial Performance
- 13.14.3. Product Benchmarking
- 13.14.4. Recent Development
- 13.15. Thermo Fisher Scientific
- 13.15.1. Company Overview
- 13.15.2. Financial Performance
- 13.15.3. Product Benchmarking
- 13.15.4. Recent Development
샘플 요청 목록